|
COPYRIGHT 2008 International Medical News Group
COLUMBUS, OHIO -- Real-time continuous glucose monitoring is likely to become the standard of care for the treatment of type 1 diabetes within the next 5-10 years, but for now it's best to reserve the technology for selected patients, Dr. Irl B. Hirsch said at a meeting on diabetes sponsored by Ohio State University.
Real-time continuous glucose monitors (RT-CGMs) have been on the market only since 2006 and are not yet indicated to replace finger-stick glucose testing. Currently, the main benefits of RT-CGMs are their capability for detecting glucose trends throughout the day and night, and their ability to alert the patient when glucose levels become too high or too low.
The potential for decreasing glucose variability--both the danger of severe hypoglycemia and the damaging oxidative stress that accompanies postprandial glucose surges--is what makes the technology so promising for the future and also valuable for some patients even now in its very...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
